|
|
|
Volumn 35, Issue 6, 2008, Pages 1029-1032
|
|
Clinical implications of bortezomib in frontline treatment of newly-diagnosed multiple myeloma
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BORONIC ACID DERIVATIVE;
BORTEZOMIB;
PYRAZINE DERIVATIVE;
ALLOTRANSPLANTATION;
CELL TRANSPLANTATION;
DRUG TOXICITY;
HUMAN;
MULTIPLE MYELOMA;
REVIEW;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BORONIC ACIDS;
CELL TRANSPLANTATION;
DRUG TOXICITY;
HUMANS;
MULTIPLE MYELOMA;
PYRAZINES;
TRANSPLANTATION, HOMOLOGOUS;
|
|
EID: 48249130925
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (3)
|
|
References (22)
|
